SlideShare a Scribd company logo
negative impacts of antibiotics
Presented by:
Mshaan H. AL-Bgomi
outline
• Intro. to Antibiotics.
• Negative Impact.
– Allergy.
– Side Effect.
– Suppression of normal flora
– Resistance.
– Interaction.
– economic burden of antimicrobial
– Companies profits
– Environmental Hazards
• Disposal of antibiotics
Antibiotics
• Antibiotics or antibacterials are a type of
antimicrobial used in the treatment and
prevention of bacterial infection.
• Classify
– Action on bacteria
– Spectrum
– Mechanism of action
Action on bacteria
• Bacteriostatic:
– inhibits the RNA
synthesis/reproduction Inhibit
growth and reproduction of
bacteria Help the host defenses
to take over
• Bactericidal:
– disrupts the cell wall synthesis-
killing the bacteria Less reliance
on host resistance Drug works
faster than static
Spectrum
• Broad spectrum:
– antibacterials are active against both
Gram+ve and Gram-ve organisms.
• Narrow spectrum:
– antibacterials have limited activity
and are primarily only useful against
particular species of
microorganisms.
Mechanism of action
Negative Impact
– Allergy.
– Side Effect.
– Suppression of normal flora
– Resistance.
– Interaction.
– economic burden of antimicrobial
– Companies profits
– Environmental Hazards
Allergy
• Allergic drug reaction, is an adverse drug reaction that results
from a specific immunologic response to a medication.
– Pruritus
– Flushing
– Urticaria
– Angioedema
– Bronchospasm
– Laryngeal edema
– Abdominal distress
– Hypotension
Side Effect
• Penicillin's – allergy reaction, anaphylaxis
• Cephalosporin's - allergy reaction, cross reaction
with penicillin
• Tetracycline's – Photosensitivity, permanent
discoloration of the teeth
• Aminoglycosides – ototoxic, nephrotoxic
• Carbapenems – Seizures (especially with imipenem)
Confusion
Side Effect
• Macrolides – liver toxicity. GI disturbances,
• Glycopeptide – Ototoxicity, Nephrotoxicity
• Sulfonamides & trimethoprim – GI disturbances –
Photosensitivity
• Metronidazole & tinidazole – GI discomfort,
Headache, depression
• Quinolones – nausea, vomiting, and diarrhea
Suppression of normal flora
• normal flora
– Microorganisms that live on or in human bodies,
and ordinarily do not cause human diseases
• Physiological Role of normal flora
– Antagonism: acts as colonization resistance of exogenous
pathogenic microbes
– Trophism: Normal flora in the intestinal tract synthesize
nutrients that can be absorbed
– Immunoenhancement: Normal flora promotes the
development of local lymphatic tissues
Resistance
1. Spontaneous Mutation:
happen as cells replicate and acquired resistance.
2. Gene Transfer or Transferred resistance
conjugation
Resistance
Antibiotics promote resistance
• If a patient taking a course of antibiotic treatment does not
complete it
• Or forgets to take the doses regularly,
• Then resistant strains get a chance to build up
• The antibiotics also kill innocent bystanders bacteria which are
non-pathogens
• This reduces the competition for the resistant pathogens
• The use of antibiotics also promotes antibiotic resistance in
non-pathogens too
• These non-pathogens may later pass their resistance genes on
to pathogens
Resistant Infections are Dangerous
• Medication toxicity (side effects)
• Contagious
• Can pass resistance to other organisms
• Worst Case Scenario: The infection may
become resistant to all medications
(untreatable).
Interaction
• Alter the normal flora in intestine necessary
for contraceptive abs.
• Increase or inhibit CYP enzymes in liver
changing plasma conc. Of drugs
– Warfarin, digoxin, theophylline.
• Plasma protein binding
economic burden of antimicrobial
• The economic impact of antimicrobial resistant
organisms can be assessed from a number of different
perspectives, including that of society, the hospital, a
third-party payer, a government agency and the
patient.
• The total cost of antimicrobial resistance in the USA
is estimated to be approximately US$30 billion
annually
economic burden of antimicrobial
• due to the need for the use of more expensive
drugs for second line treatment
• longer stays in hospital
• as well as longer sick leave or even premature
death.
Ref. Clinical and
economic burden
of antimicrobial
resistance
Anti Infect. Ther.
6(5), 751–763
(2008)
Costs of treatmen
Representative reports of attributable costs, excess lengths of stay
and risk of mortality associated with various antimicrobial-
resistant pathogens.
• Treatment failure is the main contributor
to increased costs and can lead to:
1. additional investigations such as laboratory tests and
X-ray examinations
2. additional or alternative treatments, often much more
expensive than drugs used to treat infections caused
by sensitive organisms
3. additional side-effects from more toxic treatments,
which have to be managed
4. longer hospital stay
5. longer time off work
QUALITATIVE CONSEQUENCES
OF RESISTANCE
6. reduced quality of life
7. greater likelihood of death due to inadequate or
delayed treatment
8. increased burden on family of infected individual
9. increases in private insurance coverage
10. additional cost for hospital when hospital- acquired
infection occurs and infection control procedures
are required
QUALITATIVE CONSEQUENCES
OF RESISTANCE
11. increased cost of disease surveillance
12. increased costs to firms of absenteeism
13. possible increase in product prices due to increased
costs to firms
• These consequences, however, relate only to
the direct (and some indirect) impacts of
resistance itself.
QUALITATIVE CONSEQUENCES
OF RESISTANCE
Learning from examples
• In 2014, UK prime minister David Cameron set
up the Antimicrobial Resistance Committee,
chaired by Jim O’Neill
“Without new antibiotics, cumulative cost to the
global economy by 2050 could be as much as $100
trillion. (For comparison, the total global GDP in
2014 was some $77 trillion.).He suggests that we
could buy ourselves out of an antibiotic-resistant
world by investing about $40 billion in research
over the next 10 years.”
Companies profits
• Pharmaceutical companies have developed the vast
majority of medicines known to humankind, but they
have profited handsomely from doing so
Companies profits
World's largest pharmaceutical firms
Company
Total revenue
($bn)
R&D spend
($bn)
Sales and
marketing
spend($bn)
Profit ($bn)
Profit margin
(%)
Johnson &
Johnson (US)
71.3 8.2 17.5 13.8 19
Novartis
(Swiss)
58.8 9.9 14.6 9.2 16
Pfizer (US) 51.6 6.6 11.4 22.0 43
Hoffmann-La
Roche (Swiss)
50.3 9.3 9.0 12.0 24
Sanofi
(France)
44.4 6.3 9.1 8.5 11
Merck (US) 44.0 7.5 9.5 4.4 10
GSK (UK) 41.4 5.3 9.9 8.5 21
AstraZeneca
(UK)
25.7 4.3 7.3 2.6 10
Eli Lilly (US) 23.1 5.5 5.7 4.7 20
AbbVie (US) 18.8 2.9 4.3 4.1 22
Environmental Hazards
• Pollution by antibiotic resistance genes can increase the
chances of human pathogens for acquiring resistance.
The release of residues containing human microbiota
into environments containing bacteria enriched in
resistance elements increases the possibility of
acquiring novel resistance determinants by human-
linked bacteria. For this reason, it has been proposed
that the release of residues from hospitals that contain
human commensal and infective bacteria (resistant and
susceptible) as well as antibiotics, should be reduced to
a minimum to avoid interchange of genetic material
Disposal of antibiotics
• Quantities of AB despenced to patient should
be enough for the trearment course, not more
not less!!
• According to WHO disposal of AB is in two
forms
– Solid AB:
• Crushed then incinerate
– Liquid AB:
• Diluted then sewage disposal.
Negative impacts of antibiotics

More Related Content

What's hot

The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...
Johns Hopkins University
 
Antibiotic resistant bacteria
Antibiotic resistant bacteriaAntibiotic resistant bacteria
Antibiotic resistant bacteriaNicole Glenn
 
Campaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistanceCampaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistance
guest3008cc
 
Antibiotic resistance dr sachin
Antibiotic resistance dr sachinAntibiotic resistance dr sachin
Antibiotic resistance dr sachin
Sachin Verma
 
Introduction to antibiotic resistance
Introduction to antibiotic resistanceIntroduction to antibiotic resistance
Introduction to antibiotic resistance
MikylaJRata
 
ANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCEANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCE
Kushal Saha
 
Antimicrobial stewardship in primary care
Antimicrobial stewardship in primary careAntimicrobial stewardship in primary care
Antimicrobial stewardship in primary care
THL
 
Antimicrobial resistance: Antibiotic resistance aproach.
Antimicrobial resistance: Antibiotic resistance aproach.Antimicrobial resistance: Antibiotic resistance aproach.
Antimicrobial resistance: Antibiotic resistance aproach.
Dra. Leslie Millan
 
Tackling MDR bacteria
Tackling MDR bacteriaTackling MDR bacteria
Tackling MDR bacteria
PathKind Labs
 
Antimicrobial resistance new
Antimicrobial resistance newAntimicrobial resistance new
Antimicrobial resistance new
pgims,rohtak
 
Overuse & Misuse of Antibiotics
Overuse & Misuse of AntibioticsOveruse & Misuse of Antibiotics
Overuse & Misuse of Antibiotics
Dr. Rajat Sachdeva
 
Multiple Drug Resistance and Antibiotic Misuse In English.
Multiple Drug Resistance and Antibiotic Misuse In English.Multiple Drug Resistance and Antibiotic Misuse In English.
Multiple Drug Resistance and Antibiotic Misuse In English.
Education Front
 
Antimicrobial Resistance
Antimicrobial Resistance Antimicrobial Resistance
Antimicrobial Resistance
Stabicon Life Sciences Pvt. Ltd
 
Evolution of antibiotic resistance
Evolution of antibiotic resistanceEvolution of antibiotic resistance
Evolution of antibiotic resistance
ahmet varis
 
emerging antibiotic resistance
emerging antibiotic resistanceemerging antibiotic resistance
emerging antibiotic resistance
Dr Mayank Mohan Agarwal
 
New critical care issues 2015 17
New critical care issues 2015 17New critical care issues 2015 17
New critical care issues 2015 17
samirelansary
 
Antibiotic resistance -aveen omer
Antibiotic resistance -aveen omerAntibiotic resistance -aveen omer
Antibiotic resistance -aveen omer
AveenOmer
 
Antibiotic Resistance
Antibiotic ResistanceAntibiotic Resistance
Antibiotic Resistance
SayantanDas85
 
ANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCEANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCE
RashidKwdr2
 

What's hot (19)

The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...
 
Antibiotic resistant bacteria
Antibiotic resistant bacteriaAntibiotic resistant bacteria
Antibiotic resistant bacteria
 
Campaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistanceCampaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistance
 
Antibiotic resistance dr sachin
Antibiotic resistance dr sachinAntibiotic resistance dr sachin
Antibiotic resistance dr sachin
 
Introduction to antibiotic resistance
Introduction to antibiotic resistanceIntroduction to antibiotic resistance
Introduction to antibiotic resistance
 
ANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCEANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCE
 
Antimicrobial stewardship in primary care
Antimicrobial stewardship in primary careAntimicrobial stewardship in primary care
Antimicrobial stewardship in primary care
 
Antimicrobial resistance: Antibiotic resistance aproach.
Antimicrobial resistance: Antibiotic resistance aproach.Antimicrobial resistance: Antibiotic resistance aproach.
Antimicrobial resistance: Antibiotic resistance aproach.
 
Tackling MDR bacteria
Tackling MDR bacteriaTackling MDR bacteria
Tackling MDR bacteria
 
Antimicrobial resistance new
Antimicrobial resistance newAntimicrobial resistance new
Antimicrobial resistance new
 
Overuse & Misuse of Antibiotics
Overuse & Misuse of AntibioticsOveruse & Misuse of Antibiotics
Overuse & Misuse of Antibiotics
 
Multiple Drug Resistance and Antibiotic Misuse In English.
Multiple Drug Resistance and Antibiotic Misuse In English.Multiple Drug Resistance and Antibiotic Misuse In English.
Multiple Drug Resistance and Antibiotic Misuse In English.
 
Antimicrobial Resistance
Antimicrobial Resistance Antimicrobial Resistance
Antimicrobial Resistance
 
Evolution of antibiotic resistance
Evolution of antibiotic resistanceEvolution of antibiotic resistance
Evolution of antibiotic resistance
 
emerging antibiotic resistance
emerging antibiotic resistanceemerging antibiotic resistance
emerging antibiotic resistance
 
New critical care issues 2015 17
New critical care issues 2015 17New critical care issues 2015 17
New critical care issues 2015 17
 
Antibiotic resistance -aveen omer
Antibiotic resistance -aveen omerAntibiotic resistance -aveen omer
Antibiotic resistance -aveen omer
 
Antibiotic Resistance
Antibiotic ResistanceAntibiotic Resistance
Antibiotic Resistance
 
ANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCEANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCE
 

Similar to Negative impacts of antibiotics

Antimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobindaAntimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobinda
GOBINDA PRASAD PRADHAN
 
Antibiotics gl.pptx
Antibiotics gl.pptxAntibiotics gl.pptx
WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?
WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?   WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?
WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?
Society for Microbiology and Infection care
 
Diagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policyDiagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policy
Society for Microbiology and Infection care
 
Antibiotics Success and Failures what is our role by Dr.T.V.Rao MD
AntibioticsSuccess and Failureswhat is our role by Dr.T.V.Rao MDAntibioticsSuccess and Failureswhat is our role by Dr.T.V.Rao MD
Antibiotics Success and Failures what is our role by Dr.T.V.Rao MD
Society for Microbiology and Infection care
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
Dr. Kiran Dhamak
 
Presentation on antimicrobial resistance
Presentation on antimicrobial resistancePresentation on antimicrobial resistance
Presentation on antimicrobial resistance
Matthew Frimpong Antwi
 
Antibiotic Resistance Scenario in India
Antibiotic Resistance Scenario in IndiaAntibiotic Resistance Scenario in India
Antibiotic Resistance Scenario in India
Govt.college,Nagda, ujjain.M.P
 
9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs
Yaser Ammar
 
AMR.pptx
AMR.pptxAMR.pptx
AMR.pptx
SohaGalal2
 
Anti microbial resistance
Anti microbial resistanceAnti microbial resistance
Anti microbial resistance
OKELLO ISAAC OPIO
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistance
Santosh Reddy
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistance
Santosh Reddy
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
MumtahinaZaman1
 
An tibiotic policy in medical care seminar
An tibiotic policy in medical care seminarAn tibiotic policy in medical care seminar
An tibiotic policy in medical care seminar
deepak deshkar
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
faa060129
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
SaheedAbdulbasit
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
SaheedAbdulbasit
 
Antibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmaciesAntibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmacies
Ahmed Gamal Afify
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & Arnab
Arghya Chowdhury
 

Similar to Negative impacts of antibiotics (20)

Antimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobindaAntimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobinda
 
Antibiotics gl.pptx
Antibiotics gl.pptxAntibiotics gl.pptx
Antibiotics gl.pptx
 
WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?
WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?   WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?
WHY THE ANTIBIOTICS ARE DANGEROUS TO OUR LIFE?
 
Diagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policyDiagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policy
 
Antibiotics Success and Failures what is our role by Dr.T.V.Rao MD
AntibioticsSuccess and Failureswhat is our role by Dr.T.V.Rao MDAntibioticsSuccess and Failureswhat is our role by Dr.T.V.Rao MD
Antibiotics Success and Failures what is our role by Dr.T.V.Rao MD
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
 
Presentation on antimicrobial resistance
Presentation on antimicrobial resistancePresentation on antimicrobial resistance
Presentation on antimicrobial resistance
 
Antibiotic Resistance Scenario in India
Antibiotic Resistance Scenario in IndiaAntibiotic Resistance Scenario in India
Antibiotic Resistance Scenario in India
 
9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs
 
AMR.pptx
AMR.pptxAMR.pptx
AMR.pptx
 
Anti microbial resistance
Anti microbial resistanceAnti microbial resistance
Anti microbial resistance
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistance
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistance
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
An tibiotic policy in medical care seminar
An tibiotic policy in medical care seminarAn tibiotic policy in medical care seminar
An tibiotic policy in medical care seminar
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
 
Antibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmaciesAntibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmacies
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & Arnab
 

Recently uploaded

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Negative impacts of antibiotics

  • 1. negative impacts of antibiotics Presented by: Mshaan H. AL-Bgomi
  • 2. outline • Intro. to Antibiotics. • Negative Impact. – Allergy. – Side Effect. – Suppression of normal flora – Resistance. – Interaction. – economic burden of antimicrobial – Companies profits – Environmental Hazards • Disposal of antibiotics
  • 3. Antibiotics • Antibiotics or antibacterials are a type of antimicrobial used in the treatment and prevention of bacterial infection. • Classify – Action on bacteria – Spectrum – Mechanism of action
  • 4. Action on bacteria • Bacteriostatic: – inhibits the RNA synthesis/reproduction Inhibit growth and reproduction of bacteria Help the host defenses to take over • Bactericidal: – disrupts the cell wall synthesis- killing the bacteria Less reliance on host resistance Drug works faster than static
  • 5. Spectrum • Broad spectrum: – antibacterials are active against both Gram+ve and Gram-ve organisms. • Narrow spectrum: – antibacterials have limited activity and are primarily only useful against particular species of microorganisms.
  • 7. Negative Impact – Allergy. – Side Effect. – Suppression of normal flora – Resistance. – Interaction. – economic burden of antimicrobial – Companies profits – Environmental Hazards
  • 8. Allergy • Allergic drug reaction, is an adverse drug reaction that results from a specific immunologic response to a medication. – Pruritus – Flushing – Urticaria – Angioedema – Bronchospasm – Laryngeal edema – Abdominal distress – Hypotension
  • 9. Side Effect • Penicillin's – allergy reaction, anaphylaxis • Cephalosporin's - allergy reaction, cross reaction with penicillin • Tetracycline's – Photosensitivity, permanent discoloration of the teeth • Aminoglycosides – ototoxic, nephrotoxic • Carbapenems – Seizures (especially with imipenem) Confusion
  • 10. Side Effect • Macrolides – liver toxicity. GI disturbances, • Glycopeptide – Ototoxicity, Nephrotoxicity • Sulfonamides & trimethoprim – GI disturbances – Photosensitivity • Metronidazole & tinidazole – GI discomfort, Headache, depression • Quinolones – nausea, vomiting, and diarrhea
  • 11. Suppression of normal flora • normal flora – Microorganisms that live on or in human bodies, and ordinarily do not cause human diseases • Physiological Role of normal flora – Antagonism: acts as colonization resistance of exogenous pathogenic microbes – Trophism: Normal flora in the intestinal tract synthesize nutrients that can be absorbed – Immunoenhancement: Normal flora promotes the development of local lymphatic tissues
  • 12. Resistance 1. Spontaneous Mutation: happen as cells replicate and acquired resistance. 2. Gene Transfer or Transferred resistance conjugation
  • 13.
  • 15. Antibiotics promote resistance • If a patient taking a course of antibiotic treatment does not complete it • Or forgets to take the doses regularly, • Then resistant strains get a chance to build up • The antibiotics also kill innocent bystanders bacteria which are non-pathogens • This reduces the competition for the resistant pathogens • The use of antibiotics also promotes antibiotic resistance in non-pathogens too • These non-pathogens may later pass their resistance genes on to pathogens
  • 16.
  • 17. Resistant Infections are Dangerous • Medication toxicity (side effects) • Contagious • Can pass resistance to other organisms • Worst Case Scenario: The infection may become resistant to all medications (untreatable).
  • 18. Interaction • Alter the normal flora in intestine necessary for contraceptive abs. • Increase or inhibit CYP enzymes in liver changing plasma conc. Of drugs – Warfarin, digoxin, theophylline. • Plasma protein binding
  • 19. economic burden of antimicrobial • The economic impact of antimicrobial resistant organisms can be assessed from a number of different perspectives, including that of society, the hospital, a third-party payer, a government agency and the patient. • The total cost of antimicrobial resistance in the USA is estimated to be approximately US$30 billion annually
  • 20. economic burden of antimicrobial • due to the need for the use of more expensive drugs for second line treatment • longer stays in hospital • as well as longer sick leave or even premature death.
  • 21. Ref. Clinical and economic burden of antimicrobial resistance Anti Infect. Ther. 6(5), 751–763 (2008) Costs of treatmen
  • 22. Representative reports of attributable costs, excess lengths of stay and risk of mortality associated with various antimicrobial- resistant pathogens.
  • 23. • Treatment failure is the main contributor to increased costs and can lead to: 1. additional investigations such as laboratory tests and X-ray examinations 2. additional or alternative treatments, often much more expensive than drugs used to treat infections caused by sensitive organisms 3. additional side-effects from more toxic treatments, which have to be managed 4. longer hospital stay 5. longer time off work QUALITATIVE CONSEQUENCES OF RESISTANCE
  • 24. 6. reduced quality of life 7. greater likelihood of death due to inadequate or delayed treatment 8. increased burden on family of infected individual 9. increases in private insurance coverage 10. additional cost for hospital when hospital- acquired infection occurs and infection control procedures are required QUALITATIVE CONSEQUENCES OF RESISTANCE
  • 25. 11. increased cost of disease surveillance 12. increased costs to firms of absenteeism 13. possible increase in product prices due to increased costs to firms • These consequences, however, relate only to the direct (and some indirect) impacts of resistance itself. QUALITATIVE CONSEQUENCES OF RESISTANCE
  • 26. Learning from examples • In 2014, UK prime minister David Cameron set up the Antimicrobial Resistance Committee, chaired by Jim O’Neill “Without new antibiotics, cumulative cost to the global economy by 2050 could be as much as $100 trillion. (For comparison, the total global GDP in 2014 was some $77 trillion.).He suggests that we could buy ourselves out of an antibiotic-resistant world by investing about $40 billion in research over the next 10 years.”
  • 27. Companies profits • Pharmaceutical companies have developed the vast majority of medicines known to humankind, but they have profited handsomely from doing so
  • 28. Companies profits World's largest pharmaceutical firms Company Total revenue ($bn) R&D spend ($bn) Sales and marketing spend($bn) Profit ($bn) Profit margin (%) Johnson & Johnson (US) 71.3 8.2 17.5 13.8 19 Novartis (Swiss) 58.8 9.9 14.6 9.2 16 Pfizer (US) 51.6 6.6 11.4 22.0 43 Hoffmann-La Roche (Swiss) 50.3 9.3 9.0 12.0 24 Sanofi (France) 44.4 6.3 9.1 8.5 11 Merck (US) 44.0 7.5 9.5 4.4 10 GSK (UK) 41.4 5.3 9.9 8.5 21 AstraZeneca (UK) 25.7 4.3 7.3 2.6 10 Eli Lilly (US) 23.1 5.5 5.7 4.7 20 AbbVie (US) 18.8 2.9 4.3 4.1 22
  • 29. Environmental Hazards • Pollution by antibiotic resistance genes can increase the chances of human pathogens for acquiring resistance. The release of residues containing human microbiota into environments containing bacteria enriched in resistance elements increases the possibility of acquiring novel resistance determinants by human- linked bacteria. For this reason, it has been proposed that the release of residues from hospitals that contain human commensal and infective bacteria (resistant and susceptible) as well as antibiotics, should be reduced to a minimum to avoid interchange of genetic material
  • 30. Disposal of antibiotics • Quantities of AB despenced to patient should be enough for the trearment course, not more not less!! • According to WHO disposal of AB is in two forms – Solid AB: • Crushed then incinerate – Liquid AB: • Diluted then sewage disposal.